4.8 Article

14-3-3ζ Turns TGF-β's Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2

期刊

CANCER CELL
卷 27, 期 2, 页码 177-192

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2014.11.025

关键词

-

资金

  1. NIH [P30-CA 16672, PO1-CA099031, RO1-CA112567-07]
  2. Susan G. Komen Foundation [KG091020]
  3. Cancer Prevention Research Institute of Texas [RP100726]
  4. METAvivor research grant
  5. DOD [W81XWH-10-1-0238]
  6. Sowell-Huggins Professorship
  7. Pre-doctoral Fellowship in Cancer Research

向作者/读者索取更多资源

Transforming growth factor beta (TGF-beta) functions as a tumor suppressor in premalignant cells but as a metastasis promoter in cancer cells. The dichotomous functions of TGF-beta are proposed to be dictated by different partners of its downstream effector Smads. However, the mechanism for the contextual changes of Smad partners remained undefined. Here, we demonstrate that 14-3-3 zeta destabilizes p53, a Smad partner in premalignant mammary epithelial cells, by downregulating 14-3-3 sigma, thus turning off TGF-beta's tumor suppression function. Conversely, 14-3-3 zeta stabilizes Gli2 in breast cancer cells, and Gli2 partners with Smads to activate PTHrP and promote TGF-beta-induced bone metastasis. The 14-3-3 zeta-driven contextual changes of Smad partners from p53 to Gli2 may serve as biomarkers and therapeutic targets of TGF-beta-mediated cancer progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据